| Literature DB >> 28423122 |
Michel Pompeu Barros Oliveira Sá1, Paulo Ernando Ferraz1, Artur Freire Soares1, Rodrigo Gusmão Albuquerque Miranda1, Mayara Lopes Araújo1, Frederico Vasconcelos Silva1, Ricardo de Carvalho Lima1.
Abstract
Objective: Deep sternal wound infection following coronary artery bypass grafting is a serious complication associated with significant morbidity and mortality. Despite the substantial impact of deep sternal wound infection, there is a lack of specific risk stratification tools to predict this complication after coronary artery bypass grafting. This study was undertaken to develop a specific prognostic scoring system for the development of deep sternal wound infection that could risk-stratify patients undergoing coronary artery bypass grafting and be applied right after the surgical procedure.Entities:
Mesh:
Year: 2017 PMID: 28423122 PMCID: PMC5382897 DOI: 10.21470/1678-9741-2016-0030
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Incidence of mediastinitis according to preoperative, intraoperative and postoperative variables (univariate analysis).
| Variable | Odds ratio (95% confidence interval) | |
|---|---|---|
| Age > 70 years | 1.000[ | 1.00 (0.41-2.41) |
| Male | 0.237[ | 1.50 (0.66-3.38) |
| Obesity | 0.014[ | 2.97 (1.29-6.84) |
| Hypertension | 1.000[ | 1.01 (0.30-3.48) |
| Diabetes | 0.004[ | 3.03 (1.37-6.71) |
| Smoking | 0.011[ | 2.67 (1.22-5.83) |
| Renal disease | 0.025[ | 3.21 (1.22-8.40) |
| COPD | < 0.001[ | 6.42 (2.76-14.96) |
| Previous cardiac surgery | 0.196[ | 1.97 (0.71-5.41) |
| EF < 50% | 0.036[ | 2.25 (1.03-4.89) |
| Preoperative stay > 24h | 0.680[ | 0.80 (0.70-1.10) |
| Number of bypasses | 0.648[ | 1.50 (0.62-3.63) |
| Use of ITA | 0.306[ | 0.62 (0.24-1.67) |
| Bilateral ITA | 0.071[ | 1.10 (0.20-1.90) |
| Pedicled ITA | 0.004[ | 5.28 (1.53-18.21) |
| On-pump CABG | 0.012[ | 2.92 (1.15-7.72) |
| CPB > 100 min | 0.124[ | 2.08 (0.81-5.35) |
| Additional procedure | 0.031[ | 5.54 (1.44-21.42) |
| Emergency surgery | 0.371[ | 2.46 (0.38-11.78) |
| First-year resident in the OR | 0.234[ | 1.11 (0.30-1.90) |
| Low cardiac output | 0.426[ | 1.47 (0.58-3.74) |
| Renal complications | < 0.001[ | 7.51 (3.11-18.11) |
| Respiratory complications | 0.001[ | 4.80 (2.10-10.97) |
| Infection at another site | < 0.001[ | 20.37 (8.19-51.21) |
| Reoperation | < 0.001[ | 82.4 (30.4-223.3) |
| Any blood transfusion | 0.070[ | 2.21 (0.87-5.83) |
| Multiple transfusion | 0.003[ | 3.33 (1.52-7.29) |
CABG=coronary artery bypass graft; COPD=chronic obstructive pulmonary disease; CPB=cardiopulmonary bypass; EF=ejection fraction; ITA=internal thoracic artery; OR=operation room
* Significant difference at 5.0%;
Chi-square test;
Fisher’s exact test
Fig. 1Tool to predict DSWI in patients undergoing CABG.
Fig. 2Receiver operating characteristic (ROC) curve for initial predictive model.
Fig. 3Receiver operating characteristic (ROC) curve for final predictive model.
| Abbreviations, acronyms & symbols | |
|---|---|
| aROC | = Area of receiver operating characteristic curve |
| Authors’ roles & responsibilities | |
|---|---|
| MPBOS | Conception and design; operations and/or experiments performance; analysis and/or interpretation of data; statistical analysis; manuscript writing or critical review of its content; final approval of the manuscript |
| PEF | Conception and design; operations and/or experiments performance; analysis and/or interpretation of data; statistical analysis; manuscript writing or critical review of its content; final approval of the manuscript |
| AFS | Operations and/or experiments performance; manuscript writing or critical review of its content; final approval of the manuscript |
| RGAM | Operations and/or experiments performance; manuscript writing or critical review of its content; final approval of the manuscript |
| MLA | Operations and/or experiments performance; manuscript writing or critical review of its content; final approval of the manuscript |
| FVS | Manuscript writing or critical review of its content; final approval of the manuscript |
| RCL | Manuscript writing or critical review of its content; final approval of the manuscript |